|
Part II: Matrix based scaffold lyophilization facilitates processing as a prerequisite for an innovative packaging system
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift) |
|
ID |
4663920 |
Author(s) |
Kullmann, Daniel; Lema Martinez, Carmen; Lümkemann, Jörg; Huwyler, Jörg |
Author(s) at UniBasel |
Huwyler, Jörg
|
Year |
2023 |
Title |
Part II: Matrix based scaffold lyophilization facilitates processing as a prerequisite for an innovative packaging system |
Journal |
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V |
Volume |
184 |
Pages / Article-Number |
262-273 |
Keywords |
Dual chamber bag; Freeze-drying; Intermediate process container; Scaffolds; Selective laser sintering; mAb |
Mesh terms |
Humans; Drug Packaging; Pharmaceutical Preparations; Antibodies, Monoclonal; Excipients; Freeze Drying; Glass |
Abstract |
On large manufacturing lines, the fill finish process of drugs is generally accomplished by filling vials and syringes with their respective deliverable doses. Glass as a final container provides excellent protection of the drug product because of its chemical inertia, gas impermeability and relative robustness. However, due to potential needle stitch issues, diluent mix ups, or the required use of complex closed system transfer devices, lyophilizate vials present a significant challenge for healthcare professionals during the correct preparation of intravenous (IV) infusions. A more suitable container could potentially minimize such shortfalls during the preparation of IV infusions. Our investigations aimed at assessing if a novel medication system, consisting of an infusion bag separated into individual dry product and liquid diluent chambers, could facilitate the storage of a lyophilized product equivalently to the current standard, a vial. By incorporating an intermediate process container into two different dual chamber bags (DCB), the stability of a model monoclonal antibody formulation (mAb) was studied. The DCBs were evaluated over a 24-week period against their liquid and lyophilized dosage form equivalents in glass vials. Their stability was assessed through investigations into protein stability, residual moisture uptake of the dry products and permeability of the foil and film materials. It could be demonstrated that the stability of the incorporated drug is highly dependent on the container configuration. Ultimately it could be shown that the storage of lyophilizates is equally possible in DCBs as it is in vials, while being stored next to the diluent within the administration device. |
ISSN/ISBN |
1873-3441 |
Full Text on edoc |
|
Digital Object Identifier DOI |
10.1016/j.ejpb.2022.12.007 |
PubMed ID |
http://www.ncbi.nlm.nih.gov/pubmed/36565968 |
|
|
|
MCSS v5.8 PRO. 0.322 sec, queries - 0.000 sec
©Universität Basel | Impressum
| |
09/05/2024
Research Database / FORSCHUNGSDATENBANK
|